A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people. A new preclinical model offers ...

A medication that has been prescribed in the U.S. for decades may be able to stop the earliest steps of Alzheimer’s disease— but only if it is taken long before symptoms appear, according to new ...

Beta-amyloid plaques are considered a hallmark of Alzheimer’s disease, but they’re not the sole cause of the disease and its symptoms. Alzheimer’s is a complicated disease that experts are still ...

A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people, according to a new study led by ...

In a phase 2 clinical trial, a new drug under development significantly reduced both the symptoms and disease process of a condition called Sjӧgren's disease (SjD). SJD is marked by eye and mouth ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab bested placebo in ESSDAI score at 48 weeks among patients with Sjögren’s disease. Monthly ianalumab ...

Drug Farm today announced that the U.S. Food and Drug Administration (U.S. Food and Drug Administration, FDA) has accepted DF-003, the company's investigational therapy for ROSAH syndrome, into the ...